Received Nov 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (UNKNOWN)) | UNKNOWN MANUFACTURER | 1 | — | OT / RA |
some bruising at various places on his body; Initial information received on 31-Oct-2025 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (non-healthcare professional). This case involves a 82 years old male patient (167.64 cm and 65.91 kg) who had some bruising at various places on his body after receiving NVX-COV2705 (OMICRON JN.1) Adjuvanted Vaccine [Nuvaxoid JN.1]. The patient's past vaccination(s) included INFLUENZA VACCINE in 2025. The patient's past medical history, medical treatment(s) and family history were not provided. At the time of the event, the patient had ongoing Hypertension, Depression and Gastrooesophageal reflux disease. Information related to Allergies to drugs, food or other products was not provided. Concomitant medications included: blood pressure medication, antidepressants, reflux medication, thiazide diuretics. On 24-Oct-2025, the patient received unknown dose (dose 1) of suspect NVX-COV2705 (OMICRON JN.1) Adjuvanted Vaccine, Solution for injection in pre-filled syringe, strength 5 ug (expiry date unknown) lot number not reported via intramuscular route in the right deltoid for Prophylactic vaccination (immunization). On 30-Oct-2025, the patient developed some bruising at various places on his body (contusion) (Latency 6 days). It was reported, the patient was tested positive for covid-19 in 2023, Method of Covid-19 diagnosis (e.g., antibody test, rapid antigen test, Molecular test (Nucleic acid, RNA (Ribonucleic Acid) and PCR (Polymerase Chain Reaction): Patient reports taking a test at home. Action taken was not applicable. No corrective treatment was received for the event. At time of reporting, the outcome was Not Recovered / Not Resolved for the event.
Depression; GERD; Hypertension